Benztropine Mesylate NDC 62135-142

NDC codes

FDA NDC Directory

Product NDC (as listed)62135-142Labeler and product segments. Claims need a package NDC.

Product NDC at billing width62135-0142Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
62135-142-01	62135014201	100 TABLET in 1 BOTTLE, PLASTIC (62135-142-01)Marketed from Apr 30, 2021
62135-142-10	62135014210	1000 TABLET in 1 BOTTLE, PLASTIC (62135-142-10)Marketed from Apr 30, 2021
62135-142-18	62135014218	180 TABLET in 1 BOTTLE, PLASTIC (62135-142-18)Marketed from Mar 7, 2022
62135-142-30	62135014230	30 TABLET in 1 BOTTLE, PLASTIC (62135-142-30)Marketed from Apr 30, 2021
62135-142-57	62135014257	540 TABLET in 1 BOTTLE, PLASTIC (62135-142-57)Marketed from Mar 7, 2022

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Benztropine Mesylate
Generic name (nonproprietary): benztropine mesylate
Active ingredients: Benztropine mesylate — 2 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Chartwell RX, LLC.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 081265
Marketing start: Jan 23, 1992
Listing expires: Dec 31, 2026
Other FDA classes: Cholinergic Antagonists (Mechanism)Histamine Receptor Antagonists (Mechanism)
Identifiers: Product ID 62135-142_458c005f-8842-3916-e063-6294a90a93b1SPL ID 458c005f-8842-3916-e063-6294a90a93b1SPL set ID c002005d-a478-48d4-b345-cb87edcb061fRxCUI 885209, 885213, 885219UNII WMJ8TL7510UPC 0362135142186, 0362135142575, 0362135141189, 0362135144012, 0362135144579, 0362135141578, 0362135144104, 0362135142100, 0362135144180, 0362135142018
Pharmacologic class: Anticholinergic; Antihistamine

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N462135014201 followed by a unit qualifier and the quantity

Package 62135-0142-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 9, 2025.

Indications (excerpt from the label)

INDICATIONS AND USAGE Benztropine Mesylate Tablets, USP are indicated for use as an adjunct in the therapy of all forms of parkinsonism. Useful also in the control of extrapyramidal disorders (except tardive dyskinesia-see PRECAUTIONS ) due to neuroleptic drugs (e.g., phenothiazines).

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 081265

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 081265
Product	Strength	Form · route	Labeler	Product NDC
Benztropine Mesylate	Benztropine mesylate .5 mg/1	TabletOral	Chartwell RX, LLC.	62135-141
Benztropine Mesylate	Benztropine mesylate 1 mg/1	TabletOral	Chartwell RX, LLC.	62135-144